Overview


According to FutureWise analysis the market for Histopathology Testing Equipment in 2023 is US$ 7.1 billion, and is expected to reach US$ 10.75 billion by 2031 at a CAGR of 5.32%.

Histopathology is the examination of diseases related to tissues. With the help of a microscope, the examination of tissues is done. It spots the characteristics of the disease. Histopathology testing equipment is widely utilized in medical laboratories for biological examinations. The rising cases of cancer and increasing prevalence of other chronic diseases are boosting the growth of the market.
Higher demand for advanced histopathology alongside rising cases of melanoma has accelerated the growth of the market. The demand for histopathological testing equipment has created new space for manufacturers.

The market is bifurcated on the basis of product type, by application, by the end user, and by region. The product is further divided into instruments and consumables. Instruments consist of tissue processor equipment, tissue embedding equipment, cover slipper systems, microscopes, microtome
cryostat, and others. The consumables segments consist of reagents
antibodies, probes, kits, others. The rising demands for reagents and antibodies are fueling the growth of the market. Kits and reagents are predicted to contribute to the growth of the market during the forecast. Rising demand for anatomic pathology services owing to huge usage of kits has accelerated the growth of the market. Kits are required in high number for sequencing and diagnosing of chronic diseases.

The application is segmented into drug discovery, disease diagnosis, research application. Disease diagnosis is contributing to the histopathology testing equipment. Research application is also witnessed to dominate the growth of the market in the coming years. In terms of end user, the market is segmented into hospital-based laboratories, diagnostic centres, and research organizations. Hospital-based laboratories are expected to control the growth of the market during the forecast period.
In terms of region, North America has emerged as the largest market. Presence of prominent alongside and developed healthcare infrastructure has fueled the growth of the market in the region. Asia-Pacific region is forecasted to achieve the highest growth. The rapid development of healthcare infrastructure alongside technological advancements has inflated the size of the market in the region.

  • Thermo Fisher Scientific
  • Advanced Cell Diagnostics Inc
  • Abbott Laboratories
  • Abcam
  • Omnyx
  • Qingdao Tian Hua Yi He Foundry Factory
  • Monogram Biosciences
  • Sakura Fintek

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Instruments
    • Tissue Processor Equipment
      • Automatic
      • Manual
    • Tissue Embedding Equipment
    • Slide Strainers Systems
      • High-throughput Strainers
      • Compact Strainers
    • Cover slipper Systems
    • Fully automated cover slipping workstation
    • Flexible cover slipping workstation
    • Microtome and Cryostat
      • Rotatory/Manual Microtome
      • Semi-Automatic Microtome
      • Fully Automatic Microtome
      • Manual Cryostat
      • Fully Automatic Cryostat
      • Semi-Automatic Cryostat
    • Microscopes
    • Other Instruments
  • Consumables
    • Reagents and antibodies
    • Probes
    • Kits
    • Other consumables

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Research Application

By End Users

  • Hospital-based laboratories
  • Diagnostic Centers
  • Research Organizations

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Healthcare Architecture Market By Service Type, By Facility Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Histopathology Testing Equipment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Histopathology Testing Equipment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Histopathology Testing Equipment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Histopathology Testing Equipment Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
         1.1. Tissue Processor Equipment
          1.1.1. Automatic
          1.1.2. Manual
         1.2. Tissue Embedding Equipment
         1.3. Slide Strainers Systems
          1.3.1. High-throughput Strainers
          1.3.2. Compact Strainers
         1.4. Cover slipper Systems
         1.5. Fully automated cover slipping workstation
         1.6. Flexible cover slipping workstation
         1.7. Microtome and Cryostat
          1.7.1. Rotatory/Manual Microtome
          1.7.2. Semi-Automatic Microtome
          1.7.3. Fully Automatic Microtome
          1.7.4. Manual Cryostat
          1.7.5. Fully Automatic Cryostat
          1.7.6. Semi-Automatic Cryostat
         1.8. Microscopes
         1.9. Other Instruments
        2. Consumables
         2.1. Reagents and antibodies
         2.2. Probes
         2.3. Kits
         2.4. Other consumables

  • 8.   Histopathology Testing Equipment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drug Discovery
        2. Disease Diagnosis
        3. Research Application

  • 9.   Histopathology Testing Equipment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital-based laboratories
        2. Diagnostic Centers
        3. Research Organizations

  • 10.   North America Histopathology Testing Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Histopathology Testing Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Histopathology Testing Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Histopathology Testing Equipment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Advanced Cell Diagnostics Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abcam
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Omnyx
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Qingdao Tian Hua Yi He Foundry Factory
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Monogram Biosciences
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Sakura Fintek
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients